Histoid leprosy
| Histoid leprosy | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Dermatology, Infectious disease |
| Symptoms | Skin lesions, nodules, plaques |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Mycobacterium leprae |
| Risks | |
| Diagnosis | Skin biopsy, histopathology |
| Differential diagnosis | |
| Prevention | |
| Treatment | Multidrug therapy |
| Medication | Dapsone, Rifampicin, Clofazimine |
| Prognosis | |
| Frequency | Rare |
| Deaths | N/A |
Histoid leprosy is a rare form of multibacillary leprosy, a type of leprosy characterized by numerous bacteria. It is a unique form of lepromatous leprosy with distinct clinical and histopathological features.
Clinical Features[edit]
Histoid leprosy presents as nodules and plaques on apparently normal skin, often on the posterior and lateral aspects of the arms, thighs, and buttocks. The lesions are firm, non-tender, and often have a shiny surface. The disease is often associated with resistance to dapsone therapy, a common treatment for leprosy.
Pathology[edit]
Histoid leprosy is characterized by well-defined, oval-shaped histiocytes in the dermis. These histiocytes are filled with acid-fast bacilli, which are the bacteria that cause leprosy. The bacilli are arranged in parallel bundles, giving the appearance of a "histoid" pattern.
Diagnosis[edit]
Diagnosis of histoid leprosy is based on clinical features, histopathological examination, and bacteriological index. A skin biopsy is often performed to confirm the diagnosis.
Treatment[edit]
Treatment of histoid leprosy involves multi-drug therapy, including rifampicin, clofazimine, and dapsone. This treatment is typically continued for at least 12 months, and often longer if the disease is severe.
Epidemiology[edit]
Histoid leprosy is rare, and is most commonly seen in patients who have been treated with dapsone monotherapy and have developed resistance to the drug. It is more common in men than in women, and typically affects adults.